Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Intrathoracic metastasis of ovarian cancer has poor prognosis regardless of treatment modality. Recent development of surgical techniques and the new concept of direct infusion of chemotherapeutic agents with hyperthermia could help with the treatment of disseminated diseases in ovarian cancer. Using video-assisted thoracoscopic surgery and intracavitary chemotherapy with hyperthermia, we tried hyperthermic intrathoracic chemotherapy for a case of stage IV high-grade serous ovarian cancer with pleural metastasis. There was no high-grade complication related to the procedure. The patient is alive without disease at 32 months after initial treatment.

Cite

CITATION STYLE

APA

Jun, S. Y., Seok, Y. K., Kato, T., Chun, D. S., Lee, Y. H., Chong, G. O., … Hong, D. G. (2017). Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis. Obstetrics and Gynecology Science, 60(3), 308–313. https://doi.org/10.5468/ogs.2017.60.3.308

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free